Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × pazopanib × Sarcoma × Clear all

Phase

Status

Completed 27 Terminated 11 Withdrawn 5 Active not recruiting 4 Recruiting 3 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6 Other solid neoplasm 2 Head & Neck 2 Gynecologic 2 Sarcoma 1 Breast 1

Conditions

Interventions

Doxorubicin 19 Radiotherapy 15 Cyclophosphamide 15 Ifosfamide 12 apatinib 11 anlotinib 11 Imatinib Mesylate 9 Vincristine 8 Temozolomide 8 Surgical Procedures, Operative 7 Drug Therapy 7 camrelizumab 6 Methotrexate 6 Dactinomycin 5 fludarabine phosphate 4 Paclitaxel 4 Neoadjuvant Therapy 4 Etoposide 4 Docetaxel 4 Carboplatin 4 toripalimab 3 pembrolizumab 3 Trabectedin 3 Topotecan 3 Surveys and Questionnaires 3 Nivolumab 3 Melphalan 3 Laparoscopy 3 Irinotecan 3 Endoscopic Mucosal Resection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04741438 2023-08-30

RAR-Immune

Centre Leon Berard

Phase 3 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡